|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
301 a.a.*
|
 |
|
|
|
|
|
|
|
288 a.a.*
|
 |
|
|
|
|
|
|
|
268 a.a.*
|
 |
|
|
|
|
|
|
|
235 a.a.*
|
 |
|
|
|
|
|
|
|
63 a.a.*
|
 |
|
|
|
|
* Residue conservation analysis
|
|
* C-alpha coords only
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Virus/receptor
|
 |
|
Title:
|
 |
Cryo-em structure of human poliovirus(serotype 1)complexed with three domain cd155
|
|
Structure:
|
 |
Poliovirus receptor. Chain: r. Fragment: three extracellular domains of cd155. Engineered: yes. Vp1. Chain: 1. Engineered: yes. Vp2. Chain: 2.
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Expressed in: homo sapiens. Expression_system_taxid: 9606. Expression_system_cell: kidney cells. Human poliovirus 1. Organism_taxid: 12080. Expression_system_cell: hela cells.
|
|
Authors:
|
 |
Y.He,V.D.Bowman,S.Mueller,C.M.Bator,J.Bella,X.Peng,T.S.Baker, E.Wimmer,R.J.Kuhn,M.G.Rossmann
|
Key ref:
|
 |
Y.He
et al.
(2000).
Interaction of the poliovirus receptor with poliovirus.
Proc Natl Acad Sci U S A,
97,
79-84.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
24-Nov-99
|
Release date:
|
24-Jan-00
|
|
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P15151
(PVR_HUMAN) -
Poliovirus receptor from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
417 a.a.
301 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
|
|
|
P03300
(POLG_POL1M) -
Genome polyprotein from Poliovirus type 1 (strain Mahoney)
|
|
|
|
Seq: Struc:
|
 |
 |
 |
2209 a.a.
288 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
|
|
|
P03300
(POLG_POL1M) -
Genome polyprotein from Poliovirus type 1 (strain Mahoney)
|
|
|
|
Seq: Struc:
|
 |
 |
 |
2209 a.a.
268 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
 |
|
|
 |
 |
 |
 |
Enzyme class 2:
|
 |
Chains 1, 2, 3, 4:
E.C.2.7.7.48
- RNA-directed Rna polymerase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
RNA(n) + a ribonucleoside 5'-triphosphate = RNA(n+1) + diphosphate
|
 |
 |
 |
 |
 |
RNA(n)
|
+
|
ribonucleoside 5'-triphosphate
|
=
|
RNA(n+1)
|
+
|
diphosphate
|
|
 |
 |
 |
 |
 |
 |
 |
 |
Enzyme class 3:
|
 |
Chains 1, 2, 3, 4:
E.C.3.4.22.28
- picornain 3C.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Selective cleavage of Gln-|-Gly bond in the poliovirus polyprotein. In other picornavirus reactions Glu may be substituted for Gln, and Ser or Thr for Gly.
|
 |
 |
 |
 |
 |
Enzyme class 4:
|
 |
Chains 1, 2, 3, 4:
E.C.3.4.22.29
- picornain 2A.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Selective cleavage of Tyr-|-Gly bond in the picornavirus polyprotein. In other picornavirus reactions Glu may be substituted for Gln, and Ser or Thr for Gly.
|
 |
 |
 |
 |
 |
Enzyme class 5:
|
 |
Chains 1, 2, 3, 4:
E.C.3.6.1.15
- nucleoside-triphosphate phosphatase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
a ribonucleoside 5'-triphosphate + H2O = a ribonucleoside 5'-diphosphate + phosphate + H+
|
 |
 |
 |
 |
 |
ribonucleoside 5'-triphosphate
|
+
|
H2O
|
=
|
ribonucleoside 5'-diphosphate
|
+
|
phosphate
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
Enzyme class 6:
|
 |
Chain R:
E.C.?
|
|
 |
 |
 |
 |
 |
 |
 |
|
Note, where more than one E.C. class is given (as above), each may
correspond to a different protein domain or, in the case of polyprotein
precursors, to a different mature protein.
|
|
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
Proc Natl Acad Sci U S A
97:79-84
(2000)
|
|
PubMed id:
|
|
|
|
|
| |
|
Interaction of the poliovirus receptor with poliovirus.
|
|
Y.He,
V.D.Bowman,
S.Mueller,
C.M.Bator,
J.Bella,
X.Peng,
T.S.Baker,
E.Wimmer,
R.J.Kuhn,
M.G.Rossmann.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The structure of the extracellular, three-domain poliovirus receptor (CD155)
complexed with poliovirus (serotype 1) has been determined to 22-A resolution by
means of cryo-electron microscopy and three-dimensional image-reconstruction
techniques. Density corresponding to the receptor was isolated in a difference
electron density map and fitted with known structures, homologous to those of
the three individual CD155 Ig-like domains. The fit was confirmed by the
location of carbohydrate moieties in the CD155 glycoprotein, the conserved
properties of elbow angles in the structures of cell surface molecules with
Ig-like folds, and the concordance with prior results of CD155 and poliovirus
mutagenesis. CD155 binds in the poliovirus "canyon" and has a
footprint similar to that of the intercellular adhesion molecule-1 receptor on
human rhinoviruses. However, the orientation of the long, slender CD155 molecule
relative to the poliovirus surface is quite different from the orientation of
intercellular adhesion molecule-1 on rhinoviruses. In addition, the residues
that provide specificity of recognition differ for the two receptors. The
principal feature of receptor binding common to these two picornaviruses is the
site in the canyon at which binding occurs. This site may be a trigger for
initiation of the subsequent uncoating step required for viral infection.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
Fig. 1. Comparison of the mature structures of ICAM-1,
the receptor for the major group of rhinoviruses, with the human
PV receptor (hCD155), the monkey PV receptor (mCD155), and the
murine poliovirus receptor-related protein 2 (mPRR2). Sites of
glycosylation are indicated by shaded circles. The number of
amino acids is shown for each domain.
|
 |
Figure 6.
Fig. 6. The footprint of the CD155 on the PV surface,
defined by those residues on the viral surface that have any
atoms within 4 Å of any atom in the receptor. (Inset) One
icosahedral asymmetric unit with the footprint outlined and the
limits of the canyon. (Left) The footprint on the virus (the
canyon has a black outline). (Right) The residues of CD155 in
contact with the viral surface. Each residue is colored in
accordance with its chemical properties: green, hydrophobic;
yellow, hydrophilic; red, acidic; and blue, basic.
|
 |
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
J.Seitsonen,
P.Susi,
O.Heikkilä,
R.S.Sinkovits,
P.Laurinmäki,
T.Hyypiä,
and
S.J.Butcher
(2010).
Interaction of alphaVbeta3 and alphaVbeta6 integrins with human parechovirus 1.
|
| |
J Virol,
84,
8509-8519.
|
 |
|
|
|
|
 |
M.A.Martín-Acebes,
V.Rincón,
R.Armas-Portela,
M.G.Mateu,
and
F.Sobrino
(2010).
A single amino acid substitution in the capsid of foot-and-mouth disease virus can increase acid lability and confer resistance to acid-dependent uncoating inhibition.
|
| |
J Virol,
84,
2902-2912.
|
 |
|
|
|
|
 |
V.Pliaka,
E.Dedepsidis,
Z.Kyriakopoulou,
G.Papadi,
D.Tsakogiannis,
A.Pratti,
S.Levidiotou-Stefanou,
and
P.Markoulatos
(2010).
Growth kinetic analysis of bi-recombinant poliovirus vaccine strains.
|
| |
Virus Genes,
40,
200-211.
|
 |
|
|
|
|
 |
V.Pliaka,
Z.Kyriakopoulou,
D.Tsakogiannis,
I.G.Ruether,
C.Gartzonika,
S.Levidiotou-Stefanou,
A.Krikelis,
and
P.Markoulatos
(2010).
Correlation of mutations and recombination with growth kinetics of poliovirus vaccine strains.
|
| |
Eur J Clin Microbiol Infect Dis,
29,
1513-1523.
|
 |
|
|
|
|
 |
C.C.Burns,
R.Campagnoli,
J.Shaw,
A.Vincent,
J.Jorba,
and
O.Kew
(2009).
Genetic inactivation of poliovirus infectivity by increasing the frequencies of CpG and UpA dinucleotides within and across synonymous capsid region codons.
|
| |
J Virol,
83,
9957-9969.
|
 |
|
|
|
|
 |
J.Y.Lin,
T.C.Chen,
K.F.Weng,
S.C.Chang,
L.L.Chen,
and
S.R.Shih
(2009).
Viral and host proteins involved in picornavirus life cycle.
|
| |
J Biomed Sci,
16,
103.
|
 |
|
|
|
|
 |
S.Lindert,
M.Silvestry,
T.M.Mullen,
G.R.Nemerow,
and
P.L.Stewart
(2009).
Cryo-electron microscopy structure of an adenovirus-integrin complex indicates conformational changes in both penton base and integrin.
|
| |
J Virol,
83,
11491-11501.
|
 |
|
|
|
|
 |
S.van der Sanden,
M.A.Pallansch,
J.van de Kassteele,
N.El-Sayed,
R.W.Sutter,
M.Koopmans,
and
H.van der Avoort
(2009).
Shedding of vaccine viruses with increased antigenic and genetic divergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine.
|
| |
J Virol,
83,
8693-8704.
|
 |
|
|
|
|
 |
D.Bubeck,
D.J.Filman,
M.Kuzmin,
S.D.Fuller,
and
J.M.Hogle
(2008).
Post-imaging fiducial markers aid in the orientation determination of complexes with mixed or unknown symmetry.
|
| |
J Struct Biol,
162,
480-490.
|
 |
|
|
|
|
 |
E.Dedepsidis,
V.Pliaka,
Z.Kyriakopoulou,
C.Brakoulias,
S.Levidiotou-Stefanou,
A.Pratti,
Z.Mamuris,
and
P.Markoulatos
(2008).
Complete genomic characterization of an intertypic Sabin 3/Sabin 2 capsid recombinant.
|
| |
FEMS Immunol Med Microbiol,
52,
343-351.
|
 |
|
|
|
|
 |
J.K.Odoom,
Z.Yunus,
G.Dunn,
P.D.Minor,
and
J.Martín
(2008).
Changes in population dynamics during long-term evolution of sabin type 1 poliovirus in an immunodeficient patient.
|
| |
J Virol,
82,
9179-9190.
|
 |
|
|
|
|
 |
P.Zhang,
S.Mueller,
M.C.Morais,
C.M.Bator,
V.D.Bowman,
S.Hafenstein,
E.Wimmer,
and
M.G.Rossmann
(2008).
Crystal structure of CD155 and electron microscopic studies of its complexes with polioviruses.
|
| |
Proc Natl Acad Sci U S A,
105,
18284-18289.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
S.Khan,
X.Peng,
J.Yin,
P.Zhang,
and
E.Wimmer
(2008).
Characterization of the New World monkey homologues of human poliovirus receptor CD155.
|
| |
J Virol,
82,
7167-7179.
|
 |
|
|
|
|
 |
E.Dedepsidis,
Z.Kyriakopoulou,
V.Pliaka,
C.Kottaridi,
E.Bolanaki,
S.Levidiotou-Stefanou,
D.Komiotis,
and
P.Markoulatos
(2007).
Retrospective characterization of a vaccine-derived poliovirus type 1 isolate from sewage in Greece.
|
| |
Appl Environ Microbiol,
73,
6697-6704.
|
 |
|
|
|
|
 |
E.Dedepsidis,
I.Karakasiliotis,
E.Paximadi,
Z.Kyriakopoulou,
D.Komiotis,
and
P.Markoulatos
(2006).
Detection of unusual mutation within the VP1 region of different re-isolates of poliovirus Sabin vaccine.
|
| |
Virus Genes,
33,
183-191.
|
 |
|
|
|
|
 |
K.Mitra,
and
J.Frank
(2006).
Ribosome dynamics: insights from atomic structure modeling into cryo-electron microscopy maps.
|
| |
Annu Rev Biophys Biomol Struct,
35,
299-317.
|
 |
|
|
|
|
 |
M.L.Yakovenko,
E.A.Cherkasova,
G.V.Rezapkin,
O.E.Ivanova,
A.P.Ivanov,
T.P.Eremeeva,
O.Y.Baykova,
K.M.Chumakov,
and
V.I.Agol
(2006).
Antigenic evolution of vaccine-derived polioviruses: changes in individual epitopes and relative stability of the overall immunological properties.
|
| |
J Virol,
80,
2641-2653.
|
 |
|
|
|
|
 |
S.Mueller,
D.Papamichail,
J.R.Coleman,
S.Skiena,
and
E.Wimmer
(2006).
Reduction of the rate of poliovirus protein synthesis through large-scale codon deoptimization causes attenuation of viral virulence by lowering specific infectivity.
|
| |
J Virol,
80,
9687-9696.
|
 |
|
|
|
|
 |
T.J.Tuthill,
D.Bubeck,
D.J.Rowlands,
and
J.M.Hogle
(2006).
Characterization of early steps in the poliovirus infection process: receptor-decorated liposomes induce conversion of the virus to membrane-anchored entry-intermediate particles.
|
| |
J Virol,
80,
172-180.
|
 |
|
|
|
|
 |
A.M.Milstone,
J.Petrella,
M.D.Sanchez,
M.Mahmud,
J.C.Whitbeck,
and
J.M.Bergelson
(2005).
Interaction with coxsackievirus and adenovirus receptor, but not with decay-accelerating factor (DAF), induces A-particle formation in a DAF-binding coxsackievirus B3 isolate.
|
| |
J Virol,
79,
655-660.
|
 |
|
|
|
|
 |
D.Bubeck,
D.J.Filman,
and
J.M.Hogle
(2005).
Cryo-electron microscopy reconstruction of a poliovirus-receptor-membrane complex.
|
| |
Nat Struct Mol Biol,
12,
615-618.
|
 |
|
|
|
|
 |
D.Bubeck,
D.J.Filman,
N.Cheng,
A.C.Steven,
J.M.Hogle,
and
D.M.Belnap
(2005).
The structure of the poliovirus 135S cell entry intermediate at 10-angstrom resolution reveals the location of an externalized polypeptide that binds to membranes.
|
| |
J Virol,
79,
7745-7755.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
F.Fabiola,
and
M.S.Chapman
(2005).
Fitting of high-resolution structures into electron microscopy reconstruction images.
|
| |
Structure,
13,
389-400.
|
 |
|
|
|
|
 |
N.K.Krishna
(2005).
Identification of structural domains involved in astrovirus capsid biology.
|
| |
Viral Immunol,
18,
17-26.
|
 |
|
|
|
|
 |
O.M.Kew,
R.W.Sutter,
E.M.de Gourville,
W.R.Dowdle,
and
M.A.Pallansch
(2005).
Vaccine-derived polioviruses and the endgame strategy for global polio eradication.
|
| |
Annu Rev Microbiol,
59,
587-635.
|
 |
|
|
|
|
 |
S.Berryman,
S.Clark,
P.Monaghan,
and
T.Jackson
(2005).
Early events in integrin alphavbeta6-mediated cell entry of foot-and-mouth disease virus.
|
| |
J Virol,
79,
8519-8534.
|
 |
|
|
|
|
 |
A.T.Dufresne,
and
M.Gromeier
(2004).
A nonpolio enterovirus with respiratory tropism causes poliomyelitis in intercellular adhesion molecule 1 transgenic mice.
|
| |
Proc Natl Acad Sci U S A,
101,
13636-13641.
|
 |
|
|
|
|
 |
C.Xiao,
T.J.Tuthill,
C.M.Bator Kelly,
L.J.Challinor,
P.R.Chipman,
R.A.Killington,
D.J.Rowlands,
A.Craig,
and
M.G.Rossmann
(2004).
Discrimination among rhinovirus serotypes for a variant ICAM-1 receptor molecule.
|
| |
J Virol,
78,
10034-10044.
|
 |
|
|
|
|
 |
E.A.Hewat,
and
D.Blaas
(2004).
Cryoelectron microscopy analysis of the structural changes associated with human rhinovirus type 14 uncoating.
|
| |
J Virol,
78,
2935-2942.
|
 |
|
|
|
|
 |
E.S.Johansson,
L.Xing,
R.H.Cheng,
and
D.R.Shafren
(2004).
Enhanced cellular receptor usage by a bioselected variant of coxsackievirus a21.
|
| |
J Virol,
78,
12603-12612.
|
 |
|
|
|
|
 |
H.Duque,
M.LaRocco,
W.T.Golde,
and
B.Baxt
(2004).
Interactions of foot-and-mouth disease virus with soluble bovine alphaVbeta3 and alphaVbeta6 integrins.
|
| |
J Virol,
78,
9773-9781.
|
 |
|
|
|
|
 |
J.Martín,
K.Odoom,
G.Tuite,
G.Dunn,
N.Hopewell,
G.Cooper,
C.Fitzharris,
K.Butler,
W.W.Hall,
and
P.D.Minor
(2004).
Long-term excretion of vaccine-derived poliovirus by a healthy child.
|
| |
J Virol,
78,
13839-13847.
|
 |
|
|
|
|
 |
M.J.Grubman,
and
B.Baxt
(2004).
Foot-and-mouth disease.
|
| |
Clin Microbiol Rev,
17,
465-493.
|
 |
|
|
|
|
 |
A.Avellón,
I.Casas,
G.Trallero,
C.Pérez,
A.Tenorio,
and
G.Palacios
(2003).
Molecular analysis of echovirus 13 isolates and aseptic meningitis, Spain.
|
| |
Emerg Infect Dis,
9,
934-941.
|
 |
|
|
|
|
 |
A.S.Gosselin,
Y.Simonin,
F.Guivel-Benhassine,
V.Rincheval,
J.L.Vayssière,
B.Mignotte,
F.Colbère-Garapin,
T.Couderc,
and
B.Blondel
(2003).
Poliovirus-induced apoptosis is reduced in cells expressing a mutant CD155 selected during persistent poliovirus infection in neuroblastoma cells.
|
| |
J Virol,
77,
790-798.
|
 |
|
|
|
|
 |
B.Brown,
M.S.Oberste,
K.Maher,
and
M.A.Pallansch
(2003).
Complete genomic sequencing shows that polioviruses and members of human enterovirus species C are closely related in the noncapsid coding region.
|
| |
J Virol,
77,
8973-8984.
|
 |
|
|
|
|
 |
E.Silberstein,
L.Xing,
W.van de Beek,
J.Lu,
H.Cheng,
and
G.G.Kaplan
(2003).
Alteration of hepatitis A virus (HAV) particles by a soluble form of HAV cellular receptor 1 containing the immunoglobin-and mucin-like regions.
|
| |
J Virol,
77,
8765-8774.
|
 |
|
|
|
|
 |
L.Xing,
J.M.Casasnovas,
and
R.H.Cheng
(2003).
Structural analysis of human rhinovirus complexed with ICAM-1 reveals the dynamics of receptor-mediated virus uncoating.
|
| |
J Virol,
77,
6101-6107.
|
 |
|
|
|
|
 |
M.Bomsel,
and
A.Alfsen
(2003).
Entry of viruses through the epithelial barrier: pathogenic trickery.
|
| |
Nat Rev Mol Cell Biol,
4,
57-68.
|
 |
|
|
|
|
 |
Y.He,
S.Mueller,
P.R.Chipman,
C.M.Bator,
X.Peng,
V.D.Bowman,
S.Mukhopadhyay,
E.Wimmer,
R.J.Kuhn,
and
M.G.Rossmann
(2003).
Complexes of poliovirus serotypes with their common cellular receptor, CD155.
|
| |
J Virol,
77,
4827-4835.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
A.D.Stuart,
H.E.Eustace,
T.A.McKee,
and
T.D.Brown
(2002).
A novel cell entry pathway for a DAF-using human enterovirus is dependent on lipid rafts.
|
| |
J Virol,
76,
9307-9322.
|
 |
|
|
|
|
 |
A.D.Stuart,
T.A.McKee,
P.A.Williams,
C.Harley,
S.Shen,
D.I.Stuart,
T.D.Brown,
and
S.M.Lea
(2002).
Determination of the structure of a decay accelerating factor-binding clinical isolate of echovirus 11 allows mapping of mutants with altered receptor requirements for infection.
|
| |
J Virol,
76,
7694-7704.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
E.A.Cherkasova,
E.A.Korotkova,
M.L.Yakovenko,
O.E.Ivanova,
T.P.Eremeeva,
K.M.Chumakov,
and
V.I.Agol
(2002).
Long-term circulation of vaccine-derived poliovirus that causes paralytic disease.
|
| |
J Virol,
76,
6791-6799.
|
 |
|
|
|
|
 |
F.Struyf,
W.M.Martinez,
and
P.G.Spear
(2002).
Mutations in the N-terminal domains of nectin-1 and nectin-2 reveal differences in requirements for entry of various alphaherpesviruses and for nectin-nectin interactions.
|
| |
J Virol,
76,
12940-12950.
|
 |
|
|
|
|
 |
J.M.Hogle
(2002).
Poliovirus cell entry: common structural themes in viral cell entry pathways.
|
| |
Annu Rev Microbiol,
56,
677-702.
|
 |
|
|
|
|
 |
J.Martín,
E.Samoilovich,
G.Dunn,
A.Lackenby,
E.Feldman,
A.Heath,
E.Svirchevskaya,
G.Cooper,
M.Yermalovich,
and
P.D.Minor
(2002).
Isolation of an intertypic poliovirus capsid recombinant from a child with vaccine-associated paralytic poliomyelitis.
|
| |
J Virol,
76,
10921-10928.
|
 |
|
|
|
|
 |
J.Martín,
and
P.D.Minor
(2002).
Characterization of CHAT and Cox type 1 live-attenuated poliovirus vaccine strains.
|
| |
J Virol,
76,
5339-5349.
|
 |
|
|
|
|
 |
L.Menotti,
R.Casadio,
C.Bertucci,
M.Lopez,
and
G.Campadelli-Fiume
(2002).
Substitution in the murine nectin1 receptor of a single conserved amino acid at a position distal from the herpes simplex virus gD binding site confers high-affinity binding to gD.
|
| |
J Virol,
76,
5463-5471.
|
 |
|
|
|
|
 |
M.G.Rossmann,
Y.He,
and
R.J.Kuhn
(2002).
Picornavirus-receptor interactions.
|
| |
Trends Microbiol,
10,
324-331.
|
 |
|
|
|
|
 |
Q.Xie,
W.Bu,
S.Bhatia,
J.Hare,
T.Somasundaram,
A.Azzi,
and
M.S.Chapman
(2002).
The atomic structure of adeno-associated virus (AAV-2), a vector for human gene therapy.
|
| |
Proc Natl Acad Sci U S A,
99,
10405-10410.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
W.M.Martinez,
and
P.G.Spear
(2002).
Amino acid substitutions in the V domain of nectin-1 (HveC) that impair entry activity for herpes simplex virus types 1 and 2 but not for Pseudorabies virus or bovine herpesvirus 1.
|
| |
J Virol,
76,
7255-7262.
|
 |
|
|
|
|
 |
Y.He,
F.Lin,
P.R.Chipman,
C.M.Bator,
T.S.Baker,
M.Shoham,
R.J.Kuhn,
M.E.Medof,
and
M.G.Rossmann
(2002).
Structure of decay-accelerating factor bound to echovirus 7: a virus-receptor complex.
|
| |
Proc Natl Acad Sci U S A,
99,
10325-10329.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
A.Irurzun,
and
L.Carrasco
(2001).
Entry of poliovirus into cells is blocked by valinomycin and concanamycin A.
|
| |
Biochemistry,
40,
3589-3600.
|
 |
|
|
|
|
 |
C.Xiao,
C.M.Bator,
V.D.Bowman,
E.Rieder,
Y.He,
B.Hébert,
J.Bella,
T.S.Baker,
E.Wimmer,
R.J.Kuhn,
and
M.G.Rossmann
(2001).
Interaction of coxsackievirus A21 with its cellular receptor, ICAM-1.
|
| |
J Virol,
75,
2444-2451.
|
 |
|
|
|
|
 |
F.Cocchi,
M.Lopez,
P.Dubreuil,
G.Campadelli Fiume,
and
L.Menotti
(2001).
Chimeric nectin1-poliovirus receptor molecules identify a nectin1 region functional in herpes simplex virus entry.
|
| |
J Virol,
75,
7987-7994.
|
 |
|
|
|
|
 |
J.R.Romero
(2001).
Pleconaril: a novel antipicornaviral drug.
|
| |
Expert Opin Investig Drugs,
10,
369-379.
|
 |
|
|
|
|
 |
S.K.Tsang,
B.M.McDermott,
V.R.Racaniello,
and
J.M.Hogle
(2001).
Kinetic analysis of the effect of poliovirus receptor on viral uncoating: the receptor as a catalyst.
|
| |
J Virol,
75,
4984-4989.
|
 |
|
|
|
|
 |
S.Ohka,
and
A.Nomoto
(2001).
Recent insights into poliovirus pathogenesis.
|
| |
Trends Microbiol,
9,
501-506.
|
 |
|
|
|
|
 |
W.M.Martinez,
and
P.G.Spear
(2001).
Structural features of nectin-2 (HveB) required for herpes simplex virus entry.
|
| |
J Virol,
75,
11185-11195.
|
 |
|
|
|
|
 |
Y.He,
P.R.Chipman,
J.Howitt,
C.M.Bator,
M.A.Whitt,
T.S.Baker,
R.J.Kuhn,
C.W.Anderson,
P.Freimuth,
and
M.G.Rossmann
(2001).
Interaction of coxsackievirus B3 with the full length coxsackievirus-adenovirus receptor.
|
| |
Nat Struct Biol,
8,
874-878.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
E.A.Hewat,
E.Neumann,
J.F.Conway,
R.Moser,
B.Ronacher,
T.C.Marlovits,
and
D.Blaas
(2000).
The cellular receptor to human rhinovirus 2 binds around the 5-fold axis and not in the canyon: a structural view.
|
| |
EMBO J,
19,
6317-6325.
|
 |
|
|
|
|
 |
E.J.Mancini,
and
S.D.Fuller
(2000).
Supplanting crystallography or supplementing microscopy? A combined approach to the study of an enveloped virus.
|
| |
Acta Crystallogr D Biol Crystallogr,
56,
1278-1287.
|
 |
|
|
|
|
 |
L.Xing,
K.Tjarnlund,
B.Lindqvist,
G.G.Kaplan,
D.Feigelstock,
R.H.Cheng,
and
J.M.Casasnovas
(2000).
Distinct cellular receptor interactions in poliovirus and rhinoviruses.
|
| |
EMBO J,
19,
1207-1216.
|
 |
|
|
|
|
 |
M.G.Rossmann
(2000).
Fitting atomic models into electron-microscopy maps.
|
| |
Acta Crystallogr D Biol Crystallogr,
56,
1341-1349.
|
 |
|
|
|
|
 |
P.D.Kwong,
R.Wyatt,
S.Majeed,
J.Robinson,
R.W.Sweet,
J.Sodroski,
and
W.A.Hendrickson
(2000).
Structures of HIV-1 gp120 envelope glycoproteins from laboratory-adapted and primary isolates.
|
| |
Structure,
8,
1329-1339.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
S.Neff,
P.W.Mason,
and
B.Baxt
(2000).
High-efficiency utilization of the bovine integrin alpha(v)beta(3) as a receptor for foot-and-mouth disease virus is dependent on the bovine beta(3) subunit.
|
| |
J Virol,
74,
7298-7306.
|
 |
|
|
|
|
 |
Y.Tao,
and
W.Zhang
(2000).
Recent developments in cryo-electron microscopy reconstruction of single particles.
|
| |
Curr Opin Struct Biol,
10,
616-622.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
| |